Overview

Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To estimate the duration of efficacy with continued treatment of double-blind flibanserin or placebo over twenty-four weeks of treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Sprout Pharmaceuticals, Inc